jan 1, 2014 - Pembrolizumab
Description:
Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.
Added to timeline:
Cancer
Date:
